Development of Innovative Products and Healthcare Solutions
Development of Innovative Pharmaceuticals That Address Patient Needs
Under our corporate philosophy "To broadly contribute to society through value creation based on innovative research and development activities for the betterment of healthcare and fuller lives of people worldwide," the Sumitomo Pharma Group promotes Sustainability Management. At the core of this approach lies a Material Issue: "Development of innovative products and healthcare solutions," which we regard as our most critical priority and the source of our value creation.
We aim to continuously create innovative products and healthcare solutions that address diverse medical needs in areas with high unmet medical needs. Through these efforts, we provide new therapeutic options that optimize existing treatment paradigms and offer the possibility of definitive cures, and contribute to the betterment of healthcare and fuller lives for patients, as we always stay close to patients.
We conduct drug discovery across a diverse range of approaches, from small molecule drugs to regenerative medicine/cell therapy utilizing advanced technologies, leveraging our strengths as a R&D-driven pharmaceutical company. We strive to establish a unique position worldwide as "Global Specialized Player" in the global healthcare industry.
We will strengthen our capabilities to develop innovative products and healthcare solutions, contributing to SDG Goal 3 "Good health and well-being." Thus, we will continue to be contributing to the realization of a more sustainable society, while striving to enhance our corporate value.